tiprankstipranks
Cabaletta Bio, Inc. (CABA)
NASDAQ:CABA
US Market
CABA
Cabaletta Bio
RESEARCH TOOLSreports

Cabaletta Bio (CABA) Financial Statements

1,507 Followers

Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently $348.44M. The company's EPS TTM is $-0.4; its P/E ratio is -1.34; Cabaletta Bio is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.65M$ -4.81M$ -1.43M$ -3.68M$ -733.00K
Operating Income$ -172.24M$ -125.14M$ -74.66M$ -54.14M$ -46.31M
EBITDA$ -170.59M$ -110.30M$ -66.25M$ -49.29M$ -45.56M
Net Income$ -167.86M$ -115.86M$ -67.67M$ -52.98M$ -46.29M
Balance Sheet
Cash & Short-Term Investments$ 133.60M$ 163.96M$ 241.25M$ 106.55M$ 122.22M
Total Assets$ 165.08M$ 185.05M$ 253.65M$ 116.97M$ 126.34M
Total Debt$ 27.10M$ 15.60M$ 5.02M$ 5.14M$ 0.00
Net Debt$ -55.88M$ -148.36M$ -188.22M$ -76.47M$ -122.22M
Total Liabilities$ 53.03M$ 32.71M$ 17.45M$ 12.45M$ 8.38M
Stockholders' Equity$ 112.05M$ 152.34M$ 236.20M$ 104.52M$ 117.96M
Cash Flow
Free Cash Flow$ -132.31M$ -90.43M$ -54.24M$ -48.83M$ -35.27M
Operating Cash Flow$ -131.08M$ -88.22M$ -53.55M$ -46.38M$ -34.11M
Investing Cash Flow$ -50.27M$ 47.29M$ -22.45M$ -27.22M$ 6.00M
Financing Cash Flow$ 100.35M$ 11.68M$ 187.63M$ 32.98M$ 48.90M
Currency in USD

Cabaletta Bio Earnings and Revenue History

Income Statement >

Cabaletta Bio Debt to Assets

Balance Sheet >

Cabaletta Bio Cash Flow

Cash Flow >

Cabaletta Bio Forecast EPS vs Actual EPS

Earnings >